Related Experiment Video
Updated: Jun 8, 2026

Performing Colonoscopic-Guided Pinch Biopsies in Mice and Evaluating Subsequent Tissue Changes
Published on: February 5, 2021
Mucosal healing in inflammatory bowel disease: where do we stand?
Christina Ha1, Asher Kornbluth
1Division of Gastroenterology and Hepatology, The Johns Hopkins School of Medicine, Baltimore, MD 21287, USA. christina.ha@jhmi.edu
Achieving mucosal healing in inflammatory bowel disease, including Crohn
Area of Science:
- Gastroenterology and Hepatology
- Immunology
- Internal Medicine
Background:
- The definition of remission in Crohn's disease and ulcerative colitis has evolved.
- Mucosal healing is now a key measure of treatment efficacy in inflammatory bowel disease (IBD).
- Current therapies can achieve mucosal healing in a significant number of IBD patients.
Purpose of the Study:
- To review the latest studies on the clinical outcomes of mucosal healing.
- To assess the impact of mucosal healing in both clinical trials and practice settings.
- To highlight the importance of mucosal healing as a treatment goal in IBD.
Main Methods:
- Review of recent randomized controlled trials (RCTs) and clinical practice data.
- Analysis of studies investigating the relationship between mucosal healing and patient outcomes.
- Synthesis of evidence on the attainability and benefits of mucosal healing.
Main Results:
- Mucosal healing is an achievable treatment target in Crohn's disease and ulcerative colitis.
- Achieving mucosal healing is associated with a reduced likelihood of clinical relapse.
- Mucosal healing also reduces the risk of future surgeries and hospitalizations in IBD patients.
Conclusions:
- Mucosal healing represents a critical endpoint in the management of IBD.
- The attainment of mucosal healing translates to improved long-term clinical outcomes.
- Clinicians should consider mucosal healing as a primary treatment goal for patients with IBD.
More Related Videos
07:38Multimodal Quantitative Phase Imaging with Digital Holographic Microscopy Accurately Assesses Intestinal Inflammation and Epithelial Wound Healing
Published on: September 13, 2016
07:05Important Endpoints and Proliferative Markers to Assess Small Intestinal Injury and Adaptation using a Mouse Model of Chemotherapy-Induced Mucositis
Published on: May 12, 2019
Related Concept Videos
Inflammatory Bowel Disease II: Ulcerative Colitis
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease III: Crohn's Disease
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...